Soligenix Inc
Change company Symbol lookup
Select an option...
SNGX Soligenix Inc
ABCB Ameris Bancorp
YRIV Yangtze River Port and Logistics Ltd
PINVF Pinnacle Investment Management Group Ltd
PNFPP Pinnacle Financial Partners Inc
KGHZF Pangolin Diamonds Corp
PUCCF Pancontinental Resources Corporation
PCOGF Pancontinental Oil & Gas NL
PXLIF Panaxia Labs Israel Ltd
CHPEF China PengFei Group Ltd
Go

Health Care : Biotechnology | Small Cap Blend
Company profile

Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company. The Company is focused on developing and commercializing products to treat rare diseases. The Company operates through two business segments: Specialized BioTherapeutics and Public Health Solution. Soligenix’s Specialized BioTherapeutics business segment is developing a photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma (CTCL). The Public Health Solutions business segment includes active development programs for RiVax, its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic-resistant and emerging infectious disease. CTCL is its innate defense regulator technology, dusquetide (SGX942) for the treatment of oral mucositis in head and neck cancer.

Closing Price
$0.9646
Day's Change
-0.0194 (-1.97%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.988
Day's Low
0.9425
Volume
(Below Average)
Volume:
257,052

10-day average volume:
306,318
257,052
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.